We are live on ! Find out more
EDSA icon

Edesa Biotech

17 hedge funds and large institutions have $645K invested in Edesa Biotech in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more capital invested

Capital invested by funds: $451K → $645K (+$194K)

1.28% more ownership

Funds ownership: 3.4%4.68% (+1.3%)

0% more funds holding

Funds holding: 1717 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
17
Holders Change
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

EDSA Hedge Fund Activity: Q2 2024 in Review

17 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2024, worth a combined $645K — up 43% from $451K a quarter earlier.

Fund positioning in EDSA was balanced in Q2 2024: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was CM Management, adding an estimated $125K. The largest seller was Fidelity Investments, exiting entirely with an estimated $589 sold.

  • 17 institutional investors held Edesa Biotech (EDSA) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $645K of Edesa Biotech stock for Q2 2024, up 43% quarter-over-quarter.
  • 2 funds opened new Edesa Biotech positions in Q2 2024 and 2 closed out, a net change of 0 holders.
  • The largest Edesa Biotech buyer in Q2 2024 was CM Management, an estimated $125K added.
  • The largest Edesa Biotech seller in Q2 2024 was Fidelity Investments, an estimated $589 sold.

Based on aggregated 13F filings for Q2 2024.